Ildong Pharmaceutical Co., Ltd. (KRX:249420)

South Korea flag South Korea · Delayed Price · Currency is KRW
27,750
-1,050 (-3.65%)
At close: Dec 5, 2025
147.33%
Market Cap 874.35B
Revenue (ttm) 575.66B
Net Income (ttm) 27.92B
Shares Out 31.51M
EPS (ttm) 980.97
PE Ratio 28.29
Forward PE 20.33
Dividend n/a
Ex-Dividend Date n/a
Volume 915,559
Average Volume 2,206,982
Open 28,800
Previous Close 28,800
Day's Range 27,650 - 29,400
52-Week Range 10,300 - 34,700
Beta 1.01
RSI 48.88
Earnings Date Feb 6, 2026

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system... [Read more]

Sector Healthcare
Founded 1941
Employees 1,061
Stock Exchange Korea Stock Exchange
Ticker Symbol 249420
Full Company Profile

Financial Performance

In 2024, Ildong Pharmaceutical's revenue was 614.94 billion, an increase of 2.36% compared to the previous year's 600.76 billion. Losses were -4.58 billion, -94.20% less than in 2023.

Financial Statements

News

There is no news available yet.